current management of oncogene-driven nsclc
Published 4 years ago • 61 plays • Length 7:31Download video MP4
Download video MP3
Similar videos
-
0:58
dr. shum on mechanisms of resistance in oncogene-driven nsclc
-
6:20
oncogene-driven metastatic nsclc: frontline treatment & resistance mechanisms - onctalk 2022
-
1:32
dr. goldman on the use of immunotherapy in oncogene-driven nsclc
-
4:28
understanding oncogene-driven lung cancer: targeted therapy advances and challenges
-
6:01
current management of ros1 rearranged nsclc
-
4:03
landscape of targeted therapies in lung cancer
-
37:34
managing ros1 fusion-positive nsclc in europe and the usa | panel discussion
-
6:05
treatment and management of non-small cell lung cancer (nsclc)
-
1:17
advancements in targeted therapies for oncogene-driven resectable nsclc
-
1:53
tkis in patients with oncogene driven nsclc and brain metastasis
-
58:15
current management of stage iiia non-small cell lung cancer: a changing paradigm (november 10, 2022)
-
1:16
dr. levy on treatments for oncogenic-driven nsclc
-
1:31:34
tailoring targeted therapy: new directions for managing patients across the spectrum of nsclc
-
1:50
dr. goldberg on immune/targeted therapy combos in oncogene-driven lung cancer
-
1:32
dr. goldberg on managing cns metastases in oncogene-driven nsclc
-
37:43
selective inhibition of oncogenic transcription and other approaches in the treatment of sclc
-
2:54
current frontline management of small cell lung cancer
-
1:02
dr. levy discusses the outlook for oncogene-driven nsclc
-
7:57
current treatment landscape for nsclc
-
1:15
dr. jahanzeb on immunotherapy in oncogene-driven nsclc
-
6:05
the current state of advanced nsclc treatment & contingencies
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings